Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio
- PMID: 40183258
- DOI: 10.1515/cclm-2024-1312
Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio
Abstract
Objectives: Primary aldosteronism (PA) is a common cause of secondary hypertension. The aldosterone-to-renin ratio (ARR) is the current recommended biomarker for PA screening, but it has limitations. This study evaluates another ratio, the aldosterone-to-angiotensin II ratio (AAIIR), as an alternative screening tool for PA.
Methods: Archived plasma samples for ARR from a group of 152 hypertensive patients undergoing PA screening were retrieved for AAIIR analyses. Both AAIIR and ARR were measured by liquid chromatography-mass spectrometry methods. Correlation analysis, sensitivity, specificity, and receiver operating characteristic (ROC) curve analysis were performed to assess the diagnostic performance of AAIIR relative to ARR.
Results: AAIIR showed a strong positive correlation with ARR (r=0.79, p<0.0001). The area under the ROC curve for AAIIR (0.94, 95 % CI: 0.90-0.98) was satisfactory and not significantly different from ARR (0.94, 95 % CI: 0.90-0.97, p=0.877). The optimal cutoff values were 577 (pmol/L)/(µg/L-h) and 60 for ARR and AAIIR, respectively. The sensitivity of AAIIR was slightly higher than ARR (91 vs. 88 %), while the specificity was comparable (85 vs. 86 %).
Conclusions: AAIIR demonstrates a comparable diagnostic performance to ARR for PA screening, with potential advantages in efficiency and reliability. Further large-scale studies are needed to validate its efficacy and establish its role in routine clinical practice.
Keywords: aldosterone-to-angiotensin II ratio; diagnostic performance; primary aldosteronism screening.
© 2025 the author(s), published by De Gruyter, Berlin/Boston.
References
-
- Cohen, JB, Bancos, I, Brown, JM, Sarathy, H, Turcu, AF, Cohen, DL. Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys. Annu Rev Med 2023;74:217–30. https://doi.org/10.1146/annurev-med-042921-100438 . - DOI
-
- Funder, JW, Carey, RM, Mantero, F, Murad, MH, Reincke, M, Shibata, H, et al.. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889–916. https://doi.org/10.1210/jc.2015-4061 . - DOI
-
- Raizman, JE, Diamandis, EP, Holmes, D, Stowasser, M, Auchus, R, Cavalier, E. A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. Clin Chem 2015;61:1022–7. https://doi.org/10.1373/clinchem.2015.242990 . - DOI
-
- Gordon, DB, Sachin, IN. Simultaneous measurement of PRA, PRC and PRR and the relation of renin reaction rate to renin substrate concentration. Clin Exp Hypertens(1978) 1980;2:65–87. https://doi.org/10.3109/10641968009038552 . - DOI
-
- Campbell, DJ, Nussberger, J, Stowasser, M, Danser, AH, Morganti, A, Frandsen, E, et al.. Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009;55:867–77. https://doi.org/10.1373/clinchem.2008.118000 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources